Trial Profile
Retrospective, single-site, chart review based evaluation of Apixaban in patients on dialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- 30 Jun 2017 New trial record